...
首页> 外文期刊>ACS applied materials & interfaces >BHQ-Cyanine-Based “Off–On” Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device
【24h】

BHQ-Cyanine-Based “Off–On” Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device

机译:基于BHQ-氰化的“OFF-ON”长循环组件作为癌症治疗的硬质裂菌放大器:脂质过氧化爆裂装置

获取原文
获取原文并翻译 | 示例
           

摘要

Ferroptosis is an iron-dependent cell death caused by accumulation of lipid peroxidation (LPO), which is a new strategy for cancer treatment. Th current ferroptosis therapy nanodevices have low efficiency and side effects generally. Hence, we developed a Black Hole Quencher (BHQ)-based fluorescence “off–on” nanophotosensitizer complex assembly (CSO-BHQ-IR780-Hex/MIONPs/Sor). CSO-connected BHQ-IR780-Hex and -loaded magnetic iron oxide nanoparticles (MIONPs) and sorafenib (Sor) formed a very concise functionalized delivery system. CSO-BHQ-IR780-Hex disassembled by GSH attack and released IR780-Hex, MIONPs, and sorafenib. IR780-Hex anchored to the mitochondrial membrane, which would contribute to amplifying the efficiency of the photosensitizer. When NIR irradiation was given to CSO-BHQ-IR780-Hex/MIONPs/Sor-treated cells, iron supply increased, the xCT/GSH/GPX-4 system was triggered, and a lot of LPO burst. A malondialdehyde test showed that LPO in complex assembly-treated cells was explosive and increased about 18-fold compared to the control. The accumulation process of particles was monitored by an IR780-Hex photosensitizer, which showed an excellent tumor target ability by magnetic of nanodevice in vivo. Interestingly, the half-life of sorafenib in a nanodevice was increased about 26-fold compared to the control group. Importantly, the complex assembly effectively inhibits tumor growth in the breast tumor mouse model. This work would provide ideas in designing nanomedicines for the ferroptosis treatment of cancer.
机译:脱裂病是一种由脂质过氧化(LPO)积累引起的铁依赖性细胞死亡,这是一种新的癌症治疗策略。目前的硬质溶胀疗法纳米铁通常具有低效率和副作用。因此,我们开发了一个黑洞猝灭剂(BHQ)基础的荧光“脱机”纳米光敏化剂复合物组件(CSO-BHQ-IR780-HEX / MIONPS / SOR)。 CSO连接的BHQ-IR780-HEX和 - 加载的磁性氧化铁纳米粒子(MIONPS)和索拉非尼(SOR)形成了非常简洁的功能化输送系统。 CSO-BHQ-IR780-HEX通过GSH攻击拆解并释放IR780-HEX,MIONP和Sorafenib。 IR780-HEX锚定到线粒体膜,有助于扩增光敏剂的效率。当给予CSO-BHQ-IR780-HEX / MIONPS / SOR处理的细胞NIR辐射时,铁供应增加,触发XCT / GSH / GPX-4系统,并且很多LPO爆发。丙二醛试验表明,与对照相比,复杂组装处理细胞中的LPO是爆炸性的,并增加约18倍。通过IR780-Hex光敏剂监测颗粒的累积过程,其通过体内纳米型磁性磁性显示出优异的肿瘤靶点。有趣的是,与对照组相比,纳米赛山中的索拉非尼的半衰期增加约26倍。重要的是,复杂组件有效地抑制乳腺肿瘤小鼠模型中的肿瘤生长。这项工作将在设计纳米胺的纳米胺用于治疗癌症的纳米胺的思想中提供想法。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号